TherapeuticsMD
TXMD
#10751
Rank
$20.13 M
Marketcap
$1.74
Share price
1.75%
Change (1 day)
28.89%
Change (1 year)

EPS for TherapeuticsMD (TXMD)

EPS in 2023 (TTM): $4.81

According to TherapeuticsMD's latest financial reports the company's current EPS (TTM) is $0.08000. In 2022 the company made an earnings per share (EPS) of $12.55 an increase over its 2021 EPS that were of -$21.70.

EPS history for TherapeuticsMD from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$4.81-61.67%
2022$12.55-157.83%
2021-$21.70-35.22%
2020-$33.50-5.63%
2019-$35.5020.34%
2018-$29.5055.26%
2017-$19.00-19.15%
2016-$23.50-6%
2015-$25.0042.86%
2014-$17.5052.17%
2013-$11.50-41.03%
2012-$19.50-93.62%
2011-$305.78-65.57%
2010-$888.0788.66%
2009-$470.73-32.78%
2008-$700.2916.59%
2007-$600.6626.96%
2006-$473.11-11743.27%
2005$4.06-101.88%
2004-$216.02-554.77%
2003$47.50216.55%
2002$15.01-85.01%
2001$100.11369.94%
2000$21.30404.51%
1999$4.22

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
$0.76 850.00%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
$3.57 4,363.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
-$3.87-4,937.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
$1.88 2,244.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
-$25.28-31,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA